| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycosphingolipids | 38 | 2013 | 60 | 2.900 |
Why?
|
| Phytotherapy | 9 | 2016 | 110 | 2.640 |
Why?
|
| Dietary Supplements | 8 | 2016 | 558 | 1.800 |
Why?
|
| Plants, Medicinal | 4 | 2016 | 44 | 1.570 |
Why?
|
| Complementary Therapies | 6 | 2013 | 126 | 1.540 |
Why?
|
| Herbal Medicine | 4 | 2015 | 11 | 1.190 |
Why?
|
| Blood Group Antigens | 20 | 2013 | 90 | 1.020 |
Why?
|
| Global Health | 3 | 2020 | 657 | 1.000 |
Why?
|
| G(M1) Ganglioside | 10 | 1999 | 19 | 0.980 |
Why?
|
| Low Back Pain | 2 | 2017 | 83 | 0.950 |
Why?
|
| Acupuncture Therapy | 2 | 2017 | 89 | 0.930 |
Why?
|
| Maleic Anhydrides | 2 | 2013 | 2 | 0.900 |
Why?
|
| Safety-Based Drug Withdrawals | 2 | 2013 | 3 | 0.900 |
Why?
|
| Legislation, Food | 2 | 2015 | 4 | 0.790 |
Why?
|
| Antibodies | 16 | 2013 | 838 | 0.740 |
Why?
|
| Plant Preparations | 4 | 2015 | 36 | 0.700 |
Why?
|
| Osteoarthritis, Knee | 3 | 2015 | 162 | 0.690 |
Why?
|
| Glycolipids | 16 | 1993 | 58 | 0.690 |
Why?
|
| Heart Rate | 2 | 2013 | 737 | 0.690 |
Why?
|
| United States Food and Drug Administration | 5 | 2015 | 332 | 0.680 |
Why?
|
| Curriculum | 3 | 2013 | 860 | 0.680 |
Why?
|
| Carbohydrates | 9 | 2013 | 68 | 0.640 |
Why?
|
| Allergy and Immunology | 2 | 2013 | 29 | 0.630 |
Why?
|
| Public Health | 1 | 2020 | 299 | 0.630 |
Why?
|
| Evidence-Based Medicine | 6 | 2013 | 1085 | 0.620 |
Why?
|
| Gangliosides | 17 | 1994 | 95 | 0.620 |
Why?
|
| Legislation, Drug | 2 | 2015 | 17 | 0.600 |
Why?
|
| Aristolochia | 1 | 2016 | 3 | 0.570 |
Why?
|
| Blood Pressure | 2 | 2013 | 1467 | 0.570 |
Why?
|
| Nonprescription Drugs | 2 | 2008 | 52 | 0.560 |
Why?
|
| Viscosupplements | 1 | 2015 | 10 | 0.530 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 29 | 0.530 |
Why?
|
| Ranibizumab | 1 | 2015 | 74 | 0.510 |
Why?
|
| Polyps | 1 | 2015 | 74 | 0.500 |
Why?
|
| Intermediate Filaments | 4 | 1998 | 27 | 0.500 |
Why?
|
| Lectins | 4 | 2013 | 151 | 0.480 |
Why?
|
| Autoantibodies | 7 | 1999 | 576 | 0.480 |
Why?
|
| P Blood-Group System | 13 | 1989 | 13 | 0.470 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2015 | 126 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 19 | 2003 | 4367 | 0.460 |
Why?
|
| Drug Approval | 2 | 2005 | 178 | 0.450 |
Why?
|
| Acute Disease | 1 | 2017 | 2422 | 0.430 |
Why?
|
| Antibody Specificity | 16 | 1999 | 334 | 0.420 |
Why?
|
| Vimentin | 5 | 1998 | 253 | 0.420 |
Why?
|
| Placebo Effect | 2 | 2010 | 39 | 0.410 |
Why?
|
| Pain Management | 1 | 2017 | 668 | 0.410 |
Why?
|
| Quackery | 2 | 2008 | 4 | 0.400 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 544 | 0.400 |
Why?
|
| Erythrocytes | 19 | 1988 | 339 | 0.400 |
Why?
|
| Plant Extracts | 2 | 2005 | 215 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 521 | 0.400 |
Why?
|
| Lewis X Antigen | 8 | 1996 | 46 | 0.390 |
Why?
|
| Globosides | 10 | 1992 | 16 | 0.380 |
Why?
|
| Carbohydrate Sequence | 14 | 1998 | 38 | 0.370 |
Why?
|
| Immunoglobulin Variable Region | 7 | 1999 | 173 | 0.370 |
Why?
|
| Education, Medical | 1 | 2013 | 331 | 0.340 |
Why?
|
| Genes, Immunoglobulin | 5 | 1994 | 87 | 0.340 |
Why?
|
| Rheumatic Diseases | 1 | 2009 | 54 | 0.340 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 1248 | 0.310 |
Why?
|
| Politics | 2 | 2006 | 74 | 0.310 |
Why?
|
| History, 20th Century | 4 | 2016 | 574 | 0.310 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2008 | 223 | 0.300 |
Why?
|
| Molecular Sequence Data | 17 | 1999 | 6089 | 0.290 |
Why?
|
| Professional Competence | 1 | 2008 | 136 | 0.290 |
Why?
|
| Humans | 93 | 2017 | 261506 | 0.280 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2005 | 6 | 0.270 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2006 | 208 | 0.270 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1989 | 51 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2016 | 806 | 0.250 |
Why?
|
| Cimicifuga | 1 | 2003 | 2 | 0.240 |
Why?
|
| Ephedra | 1 | 2003 | 3 | 0.240 |
Why?
|
| Immunoglobulin M | 6 | 1990 | 347 | 0.240 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2009 | 191 | 0.240 |
Why?
|
| Hot Flashes | 1 | 2003 | 37 | 0.240 |
Why?
|
| Isoflavones | 1 | 2003 | 72 | 0.230 |
Why?
|
| Menopause | 1 | 2003 | 159 | 0.230 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2008 | 410 | 0.220 |
Why?
|
| United States | 10 | 2015 | 15433 | 0.210 |
Why?
|
| Foundations | 1 | 2002 | 26 | 0.210 |
Why?
|
| Immunoglobulin Heavy Chains | 6 | 1996 | 247 | 0.210 |
Why?
|
| Osteoarthritis, Hip | 1 | 2001 | 17 | 0.210 |
Why?
|
| ABO Blood-Group System | 8 | 2003 | 127 | 0.200 |
Why?
|
| Oligosaccharides | 8 | 1996 | 110 | 0.200 |
Why?
|
| Fetal Diseases | 1 | 2005 | 388 | 0.200 |
Why?
|
| Antibody Affinity | 3 | 1996 | 61 | 0.200 |
Why?
|
| Medicine, Traditional | 1 | 2020 | 6 | 0.200 |
Why?
|
| Arthritis | 1 | 2002 | 139 | 0.190 |
Why?
|
| Drug Contamination | 2 | 2015 | 52 | 0.190 |
Why?
|
| Amino Acid Sequence | 10 | 1999 | 4233 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 526 | 0.180 |
Why?
|
| Antirheumatic Agents | 4 | 2008 | 167 | 0.180 |
Why?
|
| Bacteriophages | 2 | 1999 | 71 | 0.170 |
Why?
|
| World Health Organization | 1 | 2020 | 316 | 0.170 |
Why?
|
| Binding Sites, Antibody | 8 | 1990 | 135 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 11 | 1994 | 1062 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2017 | 1819 | 0.170 |
Why?
|
| China | 1 | 2020 | 606 | 0.170 |
Why?
|
| Teaching | 1 | 2001 | 243 | 0.170 |
Why?
|
| Endothelium | 3 | 1990 | 158 | 0.170 |
Why?
|
| Education, Medical, Continuing | 1 | 2001 | 251 | 0.170 |
Why?
|
| Base Sequence | 9 | 1999 | 4917 | 0.160 |
Why?
|
| Animals | 44 | 2016 | 59536 | 0.150 |
Why?
|
| Patient Compliance | 3 | 2008 | 667 | 0.150 |
Why?
|
| Immune Sera | 14 | 1989 | 146 | 0.150 |
Why?
|
| Silicones | 1 | 1996 | 54 | 0.140 |
Why?
|
| Medicine, Ayurvedic | 1 | 2016 | 5 | 0.140 |
Why?
|
| G(M3) Ganglioside | 3 | 1992 | 3 | 0.140 |
Why?
|
| History, Ancient | 1 | 2016 | 68 | 0.140 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 60 | 0.140 |
Why?
|
| Multiple Sclerosis | 3 | 1984 | 349 | 0.140 |
Why?
|
| Immune System Diseases | 1 | 1996 | 65 | 0.140 |
Why?
|
| Marketing | 1 | 2015 | 18 | 0.140 |
Why?
|
| Lactosylceramides | 5 | 1989 | 15 | 0.140 |
Why?
|
| Cross Reactions | 5 | 1989 | 266 | 0.140 |
Why?
|
| History, 19th Century | 1 | 2016 | 154 | 0.130 |
Why?
|
| Concanavalin A | 6 | 1987 | 67 | 0.130 |
Why?
|
| Immunoglobulins | 2 | 2001 | 266 | 0.130 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 141 | 0.130 |
Why?
|
| Fluorescein Angiography | 1 | 2015 | 139 | 0.130 |
Why?
|
| Carcinogens | 1 | 2016 | 384 | 0.130 |
Why?
|
| Neuromuscular Diseases | 2 | 1992 | 63 | 0.130 |
Why?
|
| Vitamins | 1 | 2015 | 157 | 0.130 |
Why?
|
| Mice | 23 | 2003 | 34495 | 0.130 |
Why?
|
| Vulnerable Populations | 2 | 2007 | 167 | 0.130 |
Why?
|
| Motor Neurons | 2 | 1992 | 138 | 0.130 |
Why?
|
| Immunoglobulin G | 5 | 2013 | 1021 | 0.120 |
Why?
|
| Quality Control | 2 | 2006 | 457 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2015 | 2588 | 0.120 |
Why?
|
| Urologic Neoplasms | 1 | 2016 | 188 | 0.120 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2013 | 38 | 0.120 |
Why?
|
| Pain Measurement | 1 | 2017 | 953 | 0.120 |
Why?
|
| Trihexosylceramides | 3 | 1982 | 4 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 1996 | 657 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 1993 | 201 | 0.110 |
Why?
|
| Clinical Trials as Topic | 4 | 2008 | 3719 | 0.110 |
Why?
|
| Endothelium, Vascular | 3 | 1993 | 891 | 0.110 |
Why?
|
| Fructans | 2 | 1989 | 14 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 7 | 1994 | 2314 | 0.100 |
Why?
|
| Ceramides | 6 | 1996 | 95 | 0.100 |
Why?
|
| I Blood-Group System | 2 | 1989 | 2 | 0.100 |
Why?
|
| Myocarditis | 1 | 2013 | 190 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 4 | 1996 | 109 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2015 | 873 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 441 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 501 | 0.100 |
Why?
|
| Electroacupuncture | 1 | 2010 | 35 | 0.090 |
Why?
|
| Polyradiculoneuropathy | 1 | 1990 | 9 | 0.090 |
Why?
|
| Calcium | 3 | 2015 | 1537 | 0.090 |
Why?
|
| Galactose | 4 | 1998 | 87 | 0.090 |
Why?
|
| Germ-Free Life | 1 | 1989 | 69 | 0.090 |
Why?
|
| Rabbits | 13 | 1982 | 957 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1992 | 330 | 0.090 |
Why?
|
| Lutheran Blood-Group System | 2 | 1987 | 3 | 0.090 |
Why?
|
| Paraproteinemias | 1 | 1989 | 61 | 0.090 |
Why?
|
| Professional-Patient Relations | 1 | 2010 | 124 | 0.090 |
Why?
|
| Spleen | 3 | 1991 | 676 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 1991 | 1144 | 0.090 |
Why?
|
| Female | 26 | 2015 | 141928 | 0.090 |
Why?
|
| Dextrans | 1 | 1989 | 90 | 0.090 |
Why?
|
| Cell Membrane | 6 | 1993 | 850 | 0.080 |
Why?
|
| Pain | 1 | 2017 | 1658 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 1533 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 1990 | 461 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 1999 | 1489 | 0.080 |
Why?
|
| Social Problems | 1 | 2008 | 4 | 0.080 |
Why?
|
| Portraits as Topic | 1 | 2008 | 6 | 0.080 |
Why?
|
| Homeopathy | 1 | 2008 | 9 | 0.080 |
Why?
|
| Clone Cells | 3 | 1996 | 555 | 0.080 |
Why?
|
| Pharmacopoeias as Topic | 1 | 2007 | 5 | 0.080 |
Why?
|
| Drug and Narcotic Control | 1 | 2008 | 31 | 0.080 |
Why?
|
| Structure-Activity Relationship | 3 | 1999 | 931 | 0.080 |
Why?
|
| Polysaccharides | 1 | 1989 | 197 | 0.080 |
Why?
|
| Cerebrosides | 4 | 1986 | 9 | 0.080 |
Why?
|
| Kidney | 2 | 2016 | 2146 | 0.080 |
Why?
|
| Stage-Specific Embryonic Antigens | 3 | 1994 | 7 | 0.080 |
Why?
|
| Glucosamine | 2 | 1998 | 25 | 0.080 |
Why?
|
| Antibody Formation | 3 | 1984 | 383 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 2594 | 0.080 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 3 | 1994 | 123 | 0.070 |
Why?
|
| Pregnancy | 8 | 2005 | 7573 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 787 | 0.070 |
Why?
|
| Gene Library | 2 | 1999 | 294 | 0.070 |
Why?
|
| Hemagglutination | 4 | 2003 | 13 | 0.070 |
Why?
|
| Epitopes | 4 | 1994 | 685 | 0.070 |
Why?
|
| Endosomes | 2 | 1998 | 109 | 0.070 |
Why?
|
| Budgets | 1 | 2006 | 25 | 0.070 |
Why?
|
| Trisaccharides | 1 | 1986 | 6 | 0.070 |
Why?
|
| Public Policy | 1 | 2006 | 60 | 0.070 |
Why?
|
| Social Control, Formal | 1 | 2005 | 6 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 213 | 0.070 |
Why?
|
| Immunochemistry | 3 | 2001 | 61 | 0.070 |
Why?
|
| Societies, Pharmaceutical | 1 | 2005 | 14 | 0.070 |
Why?
|
| Pharmacology, Clinical | 1 | 2005 | 10 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1999 | 611 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 2006 | 122 | 0.070 |
Why?
|
| Serine | 2 | 1998 | 388 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 4 | 1998 | 5395 | 0.070 |
Why?
|
| Trust | 1 | 2006 | 99 | 0.070 |
Why?
|
| Chromatography, Thin Layer | 5 | 1987 | 70 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 573 | 0.070 |
Why?
|
| Organizational Policy | 1 | 2005 | 73 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2006 | 203 | 0.070 |
Why?
|
| Minority Groups | 1 | 2007 | 322 | 0.060 |
Why?
|
| Lymphocyte Activation | 3 | 1987 | 1688 | 0.060 |
Why?
|
| Government Regulation | 1 | 2005 | 67 | 0.060 |
Why?
|
| Forssman Antigen | 2 | 1982 | 2 | 0.060 |
Why?
|
| DNA Primers | 2 | 1999 | 1399 | 0.060 |
Why?
|
| Phenotype | 11 | 1989 | 6295 | 0.060 |
Why?
|
| Cell Line | 5 | 1998 | 5114 | 0.060 |
Why?
|
| Phytoestrogens | 1 | 2003 | 26 | 0.060 |
Why?
|
| Synephrine | 1 | 2003 | 1 | 0.060 |
Why?
|
| Citrus | 1 | 2003 | 7 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 918 | 0.060 |
Why?
|
| Fibroblasts | 3 | 1998 | 1682 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 1983 | 151 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2017 | 32848 | 0.060 |
Why?
|
| Caffeine | 1 | 2003 | 87 | 0.060 |
Why?
|
| B-Lymphocytes | 3 | 1991 | 1294 | 0.060 |
Why?
|
| Gestational Age | 2 | 2005 | 1069 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 1213 | 0.060 |
Why?
|
| Rats | 5 | 1993 | 6086 | 0.060 |
Why?
|
| Drug Labeling | 1 | 2002 | 29 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 1996 | 223 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1999 | 99 | 0.050 |
Why?
|
| Antigens | 5 | 1989 | 292 | 0.050 |
Why?
|
| Male | 13 | 2015 | 123000 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2003 | 157 | 0.050 |
Why?
|
| Lymphocytes | 2 | 1977 | 1234 | 0.050 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2002 | 91 | 0.050 |
Why?
|
| Galactosamine | 2 | 1981 | 8 | 0.050 |
Why?
|
| Norwalk virus | 1 | 2003 | 127 | 0.050 |
Why?
|
| Models, Molecular | 2 | 1999 | 1732 | 0.050 |
Why?
|
| Virion | 1 | 2003 | 161 | 0.050 |
Why?
|
| Acetylgalactosamine | 2 | 1979 | 18 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 1544 | 0.050 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1989 | 101 | 0.050 |
Why?
|
| Holistic Health | 1 | 2001 | 11 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1989 | 830 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2002 | 553 | 0.050 |
Why?
|
| Blotting, Southern | 2 | 1992 | 406 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 95 | 0.050 |
Why?
|
| Teratoma | 1 | 1982 | 236 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2001 | 249 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 1544 | 0.050 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1990 | 73 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 792 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 748 | 0.050 |
Why?
|
| Hemagglutination Inhibition Tests | 5 | 1983 | 159 | 0.050 |
Why?
|
| Neuroglia | 2 | 1992 | 223 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2001 | 233 | 0.040 |
Why?
|
| Umbilical Veins | 2 | 1991 | 115 | 0.040 |
Why?
|
| Peptide Library | 1 | 1999 | 158 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 1982 | 741 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1987 | 548 | 0.040 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1979 | 31 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 1993 | 769 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 1978 | 48 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 1979 | 276 | 0.040 |
Why?
|
| Chloroquine | 1 | 1998 | 53 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1999 | 336 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 3 | 1984 | 115 | 0.040 |
Why?
|
| Adult | 8 | 2015 | 77950 | 0.040 |
Why?
|
| Middle Aged | 7 | 2015 | 86204 | 0.040 |
Why?
|
| Choline | 1 | 1998 | 76 | 0.040 |
Why?
|
| Liposomes | 3 | 1984 | 684 | 0.040 |
Why?
|
| Physicians | 1 | 2006 | 882 | 0.040 |
Why?
|
| Patient Satisfaction | 3 | 2010 | 915 | 0.040 |
Why?
|
| Paraproteins | 1 | 1977 | 39 | 0.040 |
Why?
|
| Ligands | 1 | 1999 | 995 | 0.040 |
Why?
|
| Insulinoma | 2 | 1989 | 55 | 0.040 |
Why?
|
| Carbohydrate Conformation | 2 | 1988 | 18 | 0.040 |
Why?
|
| Hemagglutination Tests | 6 | 1977 | 33 | 0.040 |
Why?
|
| Palatine Tonsil | 2 | 1991 | 53 | 0.040 |
Why?
|
| Acylation | 1 | 1996 | 25 | 0.030 |
Why?
|
| Sphingosine | 1 | 1996 | 55 | 0.030 |
Why?
|
| Lysosomes | 1 | 1998 | 347 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 1999 | 1487 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 1982 | 1506 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 1994 | 33 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1992 | 3203 | 0.030 |
Why?
|
| Phospholipids | 1 | 1976 | 177 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 2 | 1992 | 81 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1996 | 147 | 0.030 |
Why?
|
| Isoantibodies | 2 | 1989 | 115 | 0.030 |
Why?
|
| Ricinus | 1 | 1974 | 1 | 0.030 |
Why?
|
| Plants, Toxic | 1 | 1974 | 24 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1994 | 142 | 0.030 |
Why?
|
| Sphingolipids | 1 | 1974 | 38 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 354 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 293 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1974 | 51 | 0.030 |
Why?
|
| Aged | 3 | 2015 | 70117 | 0.030 |
Why?
|
| Ferritins | 1 | 1974 | 151 | 0.030 |
Why?
|
| Heart Block | 1 | 2013 | 48 | 0.030 |
Why?
|
| Immunodiffusion | 6 | 1980 | 46 | 0.030 |
Why?
|
| Isoantigens | 1 | 1973 | 62 | 0.030 |
Why?
|
| Bradycardia | 1 | 2013 | 70 | 0.030 |
Why?
|
| Goats | 6 | 1973 | 73 | 0.030 |
Why?
|
| Biological Transport | 1 | 1994 | 597 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1996 | 408 | 0.030 |
Why?
|
| Organelles | 1 | 1993 | 40 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 1991 | 5637 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2013 | 127 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1994 | 515 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 6869 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1993 | 241 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1992 | 239 | 0.030 |
Why?
|
| In Vitro Techniques | 5 | 1981 | 1618 | 0.030 |
Why?
|
| Communication | 2 | 2010 | 876 | 0.030 |
Why?
|
| Protein Binding | 6 | 1994 | 3438 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 261 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1991 | 40 | 0.020 |
Why?
|
| Neoplasms | 2 | 2016 | 15193 | 0.020 |
Why?
|
| Complement Fixation Tests | 5 | 1980 | 38 | 0.020 |
Why?
|
| Glycoconjugates | 1 | 1990 | 10 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 1994 | 6942 | 0.020 |
Why?
|
| Acupuncture | 1 | 2010 | 22 | 0.020 |
Why?
|
| Trypsin | 2 | 1981 | 140 | 0.020 |
Why?
|
| Erythrocyte Membrane | 2 | 1981 | 36 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1992 | 267 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1991 | 295 | 0.020 |
Why?
|
| Peptidoglycan | 1 | 1989 | 14 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1989 | 36 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1992 | 844 | 0.020 |
Why?
|
| Dogs | 1 | 1992 | 1155 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1970 | 137 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1978 | 92 | 0.020 |
Why?
|
| Agglutinins | 2 | 1981 | 19 | 0.020 |
Why?
|
| Fetus | 1 | 1973 | 601 | 0.020 |
Why?
|
| Models, Biological | 1 | 1998 | 3254 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1991 | 200 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 1992 | 1450 | 0.020 |
Why?
|
| Cold Temperature | 2 | 1981 | 121 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 2927 | 0.020 |
Why?
|
| Immunoelectrophoresis | 4 | 1980 | 40 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1991 | 247 | 0.020 |
Why?
|
| Galactans | 1 | 1988 | 4 | 0.020 |
Why?
|
| Fatty Acids | 2 | 1985 | 448 | 0.020 |
Why?
|
| Gastric Mucins | 1 | 1967 | 12 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1989 | 229 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 585 | 0.020 |
Why?
|
| Species Specificity | 1 | 1989 | 777 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 1983 | 702 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1986 | 300 | 0.020 |
Why?
|
| Osmotic Fragility | 1 | 1987 | 9 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1993 | 1620 | 0.020 |
Why?
|
| Lipoproteins | 2 | 1984 | 252 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 101 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 1987 | 13 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1987 | 22 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 4314 | 0.020 |
Why?
|
| Prognosis | 1 | 2005 | 21713 | 0.020 |
Why?
|
| Cations | 1 | 1987 | 62 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1991 | 3033 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1989 | 366 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1986 | 182 | 0.020 |
Why?
|
| Kinetics | 4 | 1984 | 2049 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1987 | 186 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 397 | 0.020 |
Why?
|
| Reference Values | 1 | 1988 | 1099 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 649 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 2307 | 0.020 |
Why?
|
| Glycosides | 2 | 1977 | 22 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 521 | 0.020 |
Why?
|
| Mitochondria | 1 | 1993 | 1282 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1987 | 309 | 0.020 |
Why?
|
| Sialic Acids | 1 | 1984 | 29 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1984 | 37 | 0.020 |
Why?
|
| Forecasting | 1 | 2008 | 694 | 0.020 |
Why?
|
| Immunization | 1 | 1986 | 397 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2005 | 52 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 1989 | 677 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2005 | 98 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2005 | 76 | 0.020 |
Why?
|
| Leukocytes | 1 | 1986 | 422 | 0.020 |
Why?
|
| Focus Groups | 1 | 2005 | 256 | 0.020 |
Why?
|
| Truth Disclosure | 1 | 2006 | 180 | 0.020 |
Why?
|
| Carbon Isotopes | 6 | 1975 | 333 | 0.020 |
Why?
|
| Arthritis, Juvenile | 1 | 1984 | 51 | 0.020 |
Why?
|
| Glycoproteins | 4 | 1974 | 747 | 0.020 |
Why?
|
| Hybridomas | 1 | 1983 | 75 | 0.010 |
Why?
|
| Glucose | 4 | 1991 | 1248 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1981 | 889 | 0.010 |
Why?
|
| Coma | 1 | 1984 | 61 | 0.010 |
Why?
|
| Drug Costs | 1 | 2005 | 144 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1984 | 259 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1987 | 842 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1991 | 4143 | 0.010 |
Why?
|
| Temperature | 2 | 2003 | 506 | 0.010 |
Why?
|
| Carcinoma | 1 | 1994 | 2578 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1984 | 142 | 0.010 |
Why?
|
| Morula | 1 | 1982 | 4 | 0.010 |
Why?
|
| T-Lymphocytes | 3 | 1984 | 3869 | 0.010 |
Why?
|
| Language | 1 | 2005 | 309 | 0.010 |
Why?
|
| Pedigree | 1 | 1987 | 1890 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1984 | 419 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 2 | 1983 | 5061 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 1980 | 624 | 0.010 |
Why?
|
| Blastocyst | 1 | 1982 | 124 | 0.010 |
Why?
|
| Methylation | 1 | 1983 | 597 | 0.010 |
Why?
|
| Galactosylceramides | 1 | 1981 | 34 | 0.010 |
Why?
|
| Diet | 1 | 1989 | 1440 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1981 | 6915 | 0.010 |
Why?
|
| Poverty | 1 | 2005 | 471 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1981 | 77 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2003 | 207 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1981 | 57 | 0.010 |
Why?
|
| Haptens | 1 | 1980 | 15 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1987 | 2084 | 0.010 |
Why?
|
| Glucosylceramides | 1 | 1980 | 5 | 0.010 |
Why?
|
| Genotype | 1 | 1989 | 4109 | 0.010 |
Why?
|
| Neurons | 1 | 1991 | 2287 | 0.010 |
Why?
|
| Models, Structural | 3 | 1974 | 103 | 0.010 |
Why?
|
| Binding Sites | 5 | 1975 | 2171 | 0.010 |
Why?
|
| Time Factors | 3 | 2007 | 12926 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1984 | 1016 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1979 | 67 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1981 | 482 | 0.010 |
Why?
|
| Mutation | 1 | 1998 | 15179 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 1287 | 0.010 |
Why?
|
| Methylglycosides | 2 | 1975 | 4 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1984 | 1375 | 0.010 |
Why?
|
| Chemistry | 2 | 1975 | 99 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1975 | 137 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1980 | 429 | 0.010 |
Why?
|
| Polylysine | 1 | 1977 | 17 | 0.010 |
Why?
|
| X-Ray Diffraction | 2 | 1975 | 168 | 0.010 |
Why?
|
| Hexoses | 1 | 1976 | 11 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1974 | 568 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 1976 | 25 | 0.010 |
Why?
|
| Glycerides | 1 | 1976 | 10 | 0.010 |
Why?
|
| Teichoic Acids | 1 | 1976 | 13 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1975 | 39 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1976 | 38 | 0.010 |
Why?
|
| Cardiolipins | 1 | 1976 | 33 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1977 | 256 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 14889 | 0.010 |
Why?
|
| Texas | 1 | 2006 | 6311 | 0.010 |
Why?
|
| Echinococcosis | 1 | 1974 | 15 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 9244 | 0.010 |
Why?
|
| Electrophoresis, Disc | 1 | 1974 | 15 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1974 | 26 | 0.010 |
Why?
|
| Ricin | 1 | 1974 | 34 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1974 | 49 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1974 | 26 | 0.010 |
Why?
|
| Methods | 1 | 1974 | 189 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1974 | 55 | 0.010 |
Why?
|
| Plant Lectins | 1 | 1974 | 27 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 4320 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1974 | 71 | 0.010 |
Why?
|
| Fucose | 2 | 1991 | 50 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1974 | 122 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1974 | 74 | 0.010 |
Why?
|
| Peptides | 1 | 1980 | 1479 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1974 | 163 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 5687 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1974 | 418 | 0.010 |
Why?
|
| Manganese | 4 | 1975 | 80 | 0.010 |
Why?
|
| Infant | 1 | 1989 | 13310 | 0.010 |
Why?
|
| Ribosomes | 1 | 1974 | 147 | 0.010 |
Why?
|
| Mucus | 1 | 1973 | 119 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1973 | 130 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1973 | 205 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1989 | 16273 | 0.010 |
Why?
|
| Sheep | 3 | 1980 | 258 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1970 | 329 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1991 | 47 | 0.010 |
Why?
|
| Mannose | 1 | 1991 | 40 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1991 | 30 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1991 | 79 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 167 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1991 | 87 | 0.010 |
Why?
|
| Antigens, CD20 | 1 | 1991 | 206 | 0.010 |
Why?
|
| Autopsy | 1 | 1991 | 173 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1991 | 151 | 0.010 |
Why?
|
| Epithelium | 1 | 1973 | 720 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1974 | 1643 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1991 | 314 | 0.010 |
Why?
|
| Transferases | 1 | 1970 | 9 | 0.010 |
Why?
|
| Child | 2 | 1989 | 29154 | 0.010 |
Why?
|
| Genes | 2 | 1970 | 491 | 0.010 |
Why?
|
| Keratins | 1 | 1991 | 330 | 0.010 |
Why?
|
| Stomach | 1 | 1973 | 387 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1974 | 15694 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1970 | 156 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1969 | 18 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1980 | 257 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1969 | 132 | 0.010 |
Why?
|
| Rheumatic Fever | 1 | 1969 | 18 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1969 | 97 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1968 | 43 | 0.010 |
Why?
|
| Zinc | 3 | 1975 | 188 | 0.010 |
Why?
|
| Fetal Death | 1 | 1969 | 113 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1969 | 207 | 0.010 |
Why?
|
| Ovarian Cysts | 1 | 1968 | 43 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1991 | 335 | 0.010 |
Why?
|
| Adolescent | 1 | 1989 | 31252 | 0.010 |
Why?
|
| Intestines | 1 | 1973 | 686 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1969 | 143 | 0.000 |
Why?
|
| Milk, Human | 1 | 1970 | 277 | 0.000 |
Why?
|
| Retina | 1 | 1991 | 532 | 0.000 |
Why?
|
| Mucins | 1 | 1968 | 285 | 0.000 |
Why?
|
| Infertility | 1 | 1969 | 123 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1976 | 2359 | 0.000 |
Why?
|
| Ovarian Diseases | 1 | 1966 | 54 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1967 | 176 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1991 | 1385 | 0.000 |
Why?
|
| Gene Frequency | 1 | 1969 | 1163 | 0.000 |
Why?
|
| Milk | 1 | 1966 | 120 | 0.000 |
Why?
|
| Neuraminidase | 2 | 1977 | 69 | 0.000 |
Why?
|
| Saliva | 1 | 1966 | 231 | 0.000 |
Why?
|
| Cysts | 1 | 1966 | 197 | 0.000 |
Why?
|
| Mitomycins | 1 | 1984 | 48 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1991 | 3536 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1984 | 97 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 37905 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 1146 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1969 | 785 | 0.000 |
Why?
|
| Swine | 1 | 1968 | 1541 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1969 | 589 | 0.000 |
Why?
|
| Mitomycin | 1 | 1984 | 208 | 0.000 |
Why?
|
| Liver | 1 | 1973 | 2961 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1974 | 3230 | 0.000 |
Why?
|
| Absorption | 1 | 1981 | 81 | 0.000 |
Why?
|
| Myelin Basic Protein | 1 | 1981 | 85 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1981 | 241 | 0.000 |
Why?
|
| Alleles | 1 | 1967 | 2437 | 0.000 |
Why?
|
| Models, Chemical | 2 | 1973 | 186 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1981 | 139 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1981 | 600 | 0.000 |
Why?
|
| Nucleoproteins | 1 | 1960 | 37 | 0.000 |
Why?
|
| Myelin Sheath | 1 | 1981 | 149 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1991 | 2819 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1980 | 196 | 0.000 |
Why?
|
| Protein Conformation | 2 | 1973 | 1258 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 7548 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 2138 | 0.000 |
Why?
|
| Alanine | 1 | 1980 | 240 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 7222 | 0.000 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1991 | 2796 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1981 | 690 | 0.000 |
Why?
|
| Papain | 1 | 1977 | 8 | 0.000 |
Why?
|
| Hemadsorption | 1 | 1974 | 6 | 0.000 |
Why?
|
| Clostridium perfringens | 1 | 1974 | 9 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1975 | 171 | 0.000 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1974 | 62 | 0.000 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1973 | 14 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1974 | 145 | 0.000 |
Why?
|
| Cobalt | 1 | 1973 | 55 | 0.000 |
Why?
|
| Mathematics | 1 | 1973 | 136 | 0.000 |
Why?
|
| Magnesium | 1 | 1973 | 160 | 0.000 |
Why?
|
| Fourier Analysis | 1 | 1973 | 94 | 0.000 |
Why?
|
| Cattle | 1 | 1974 | 783 | 0.000 |
Why?
|
| Chromatography, Paper | 1 | 1970 | 6 | 0.000 |
Why?
|
| Guanine Nucleotides | 1 | 1970 | 23 | 0.000 |
Why?
|